Whoopee. Biogen is FINALLY going to let people see
Post# of 1460
Quote:
Madhav Thambisetty, a senior investigator at NIH’s National Institute on Aging, previously told Endpoints that the published data “will enable clinicians like myself in our decision-making. For instance, it would be important to understand whether the drug accelerated brain atrophy in the clinical trial participants. Loss of brain volume has been reported with other amyloid lowering antibodies and while serial MR imaging of the brain was performed in the two phase-3 trials of aducanumab, we do not yet know if this drug results in accelerated brain atrophy in patients .”
https://endpts.com/scoop-biogen-will-finally-...r-aduhelm/